Abstract
2-Aminoethoxydiphenyl borate (2-APB), a commonly used blocker of IP3-induced calcium ion release and of store-operated channels, inhibits gap junction conductance when applied to cultured cells. The character and pharmacology of this inhibition was explored using 1) hemichannels composed of connexin32 (Cx32) and/or connexin26 (Cx26) purified from native sources and from transfected HeLa cells in which the connexin had a cleavable C-terminal epitope tag and 2) the corresponding junctional channels. Using reconstituted hemichannels in a liposome-based transport-specific fractionation assay (TSF), 2-APB reversibly inhibited homomeric Cx32 and heteromeric Cx26/Cx32 channels from native tissue and their tagged forms from HeLa cells. The IC50-TSF value of the inhibition was ∼47 μM at pH 6.5. 2-APB did not inhibit tagged homomeric Cx26 channels even after tag cleavage (leaving several amino acids at the carboxyl terminus). Protonated 2-APB is the inhibitory agent, but channel sensitivity to 2-APB also increases as pH is lowered. To help define the chemical requirements for inhibition, the effects of four structural analogs of 2-APB were determined. The inhibitory action of 2-APB was shown to be distinct from that of aminosulfonates. 2-APB and its analogs, except phenytoin, inhibited dye-coupling through junctional channels formed by all the tagged channel forms except Cx26, consistent with the TSF studies. However 2-APB significantly inhibited dye coupling between cells expressing untagged Cx26, suggesting that an unmodified C terminus is required for action on Cx26 channels. These results show that protonated 2-APB directly and reversibly inhibits connexin channels composed of Cx26 and/or Cx32 and suggest involvement of the carboxyl-terminal domain.
Footnotes
-
This work was supported by National Institutes of Health grants GM36044 and GM61406 and by a seed grant from the University of Medicine and Dentistry of New Jersey Foundation Research Program (to A.L.H.).
-
ABBREVIATIONS: 2-APB, 2-aminoethoxydiphenyl borate; Cx26, connexin26; Cx32, connexin32; Cx26/Cx32, heteromeric connexin26/connexin32 channels; DPBA, diphenylboronic anhydride; DPDM, diphenhydramine; DPTTF, 2,2 diphenyltetrahydrofuran; HA, hemagglutinin; IP3, inositol triphosphate; OG, n-octyl-β-d-glucoside; TSF, transport-specific fractionation; T, C-terminal epitope tag; Tc, thrombin-cleaved epitope tag.
- Received June 6, 2006.
- Accepted November 9, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|